TUMORILE RENALE LA COPII - TUMORA WILMS
DOI:
https://doi.org/10.52692/1857-0011.2022.2-73.04Cuvinte cheie:
tumoră renală, chist renal, clasificare Bosniak, Tumora WilmsRezumat
Tumorile renale reprezintă între 4,4% și 6,3% din formațiunile tumorale maligne ale populației pediatrice1, ceea ce face necesară o cunoaștere a tipurilor de formațiuni tumorale ce pot apărea la aceasta categorie de vârsta în scopul unui diagnostic si tratament adecvat.
Referințe
Coran AG, Adzick SS, Krummel T, Caldamone A.Pediatric Surgery.; 2012. doi:10.1016/C2009-0-41746-X
Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell-Walsh Urology 11th Edition. Elsevier. 2015.
Gaillard F, Weerakkody Y. Bosniak classification system of renal cystic masses. Radiopaedia.org. doi:https://doi.org/10.53347/rID-1006
Schieda N, Davenport MS, Krishna S, et al. Bosniak classification of cystic renal masses, version 2019: A pictorial guide to clinical use. Radiographics. 2021. doi:10.1148/rg.2021200160
Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak classification of cystic renal masses, version 2019: An update proposal and needs assessment. Radiology. 2019. doi:10.1148/radiol.2019182646
Lucocq J, Pillai S, Oparka R, Nabi G. Complex renal cysts (Bosniak ≥IIF): interobserver agreement, progression and malignancy rates. Eur Radiol. 2021. doi:10.1007/s00330-020-07186-w
Bosniak classification system of renal cystic masses| Radiology Reference Article | Radiopaedia.org. https://radiopaedia.org/articles/bosniak-classification-system-of-renal-cystic-masses. Accessed April 12, 2022.
Wang KL, Weinrach DM, Luan C, et al. Renal papillary adenoma-a putative precursor of papillary renal cell carcinoma. Hum Pathol. 2007. doi:10.1016/j.humpath.2006.07.016
Sethi D, Khetarpal S, Ahluvalia C, Arora H. Renal angiomyolipoma: A radiopathological diagnosis. Clin Cancer Investig J. 2012. doi:10.4103/2278-0513.99582
Baio R, Spiezia N, Schettini M. Cystic nephroma treated with nephron-sparing technique: A case report. Mol Clin Oncol. 2021. doi:10.3892/mco.2021.2271
Fischbach B V., Trout KL, Lewis J, Luis CA, Sika M. WAGR syndrome: A clinical review of 54 cases. Pediatrics. 2005. doi:10.1542/peds.2004-0467
Gariépy-Assal L, Gilbert RD, Žiaugra A, Foster BJ. Management of Denys-Drash syndrome: A case series based on an international survey. Clin Nephrol – Case Stud. 2018. doi:10.5414/cncs109515
Morris MR, Astuti D, Maher ER. Perlman Syndrome: Overgrowth, Wilms Tumor Predisposition and DIS3L2. Am J Med Genet Part C Semin Med Genet. 2013. doi:10.1002/ajmg.c.31358
Routh JC, Ashley RA, Sebo TJ, et al. B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence. J Urol. 2008. doi:10.1016/j.juro.2008.01.056
Phelps HM, Kaviany S, Borinstein SC, Lovvorn HN. Biological drivers of wilms tumor prognosis and treatment. Children. 2018. doi:10.3390/children5110145
Lizhi L, Rongdong H, Shaohua H, et al. Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis. Fetal Pediatr Pathol. 2021. doi:10.1080/15513815.2020.1725937
Schoen FJ, Mitchell RN. Robbins & Cotran Pathologic Basis of Disease. Elsevier Inc. 2015.
Davidoff AM. Wilms Tumor. Adv Pediatr. 2012. doi:10.1016/j.yapd.2012.04.001
Szychot E, Apps J, Pritchard-Jones K. Wilms’ tumor: biology, diagnosis and treatment. Transl Pediatr. 2014;3(1):12. doi:10.3978/J.ISSN.2224-4336.2014.01.09
Spreafico F, Bellani FF. Wilms’ tumor: Past, present and (possibly) future. Expert Rev Anticancer Ther. 2006. doi:10.1586/14737140.6.2.249
Wu HY, Snyder HM, D’Angio GJ. Wilms’ tumor management. Curr Opin Urol. 2005. doi:10.1097/01.mou.0000172403.69890.eb
Ritchey ML, Green DM, Thomas PRM, et al. Renal failure in Wilms’ tumor patients: A report from the National Wilms’ Tumor Study Group. Med Pediatr Oncol. 1996. doi:10.1002/(SICI)1096-911X(199602)26:2<75::AIDMPO1>3.0.CO;2-R.
Descărcări
Publicat
Număr
Secțiune
Licență
Copyright (c) 2022 Buletinul Academiei de Științe a Moldovei. Științe medicale
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Această lucrare este licențiată în temeiul Creative Commons Attribution 4.0 International License.